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Abstract
Background: KPC-producing carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are associated with high
mortality; however, their virulence determinants are not well defined.
Methods: We investigated the virulence and plasmid transferability among KPC-containing K. pneumoniae isolates.
Results: KPC-2 and −3 were successfully conjugated and retained by a virulent K2 K. pneumoniae recipient isolate.
Antimicrobial susceptibility testing showed KPC-2 and −3 donor strains were resistant to more than four classes of
antibiotics while the K2 isolate was only initially resistant to ampicillin. After conjugation of KPC-2 and −3, the K2
K. pneumoniae transconjugants became resistant to all beta-lactams. Additionally, the KPC K2 K. pneumoniae
transconjugants continued to retain its high serum resistance and murine lethality.
Conclusions: Conjugation and retainment of KPC by virulent K2 K. pneumoniae and the ability of the
tranconjugants to maintain its high serum resistance and murine lethality after conjugation was demonstrated in
this study. These findings are concerning for the potential of KPC-like genes to disseminate among virulent
K. pneumoniae isolates.
Keywords: Klebsiella pneumoniae, Virulence, Plasmid mediated resistance
Background
In the Asia Pacific Rim, a pathogen that is well docu-
mented is the hypervirulent (hypermucoviscous) variant
of Klebsiella pneumoniae. This pathogen causes unique
clinical invasive syndromes of community-acquired K.
pneumoniae infections including pyogenic liver abscess
and a propensity for metastatic spread to distant sites in
the absence of a history of hepatobiliary disease [1-3]. In
Western countries, the predominant infections due to
K. pneumoniae are still the “classic” strains. Infections
caused by K. pneumoniae can result in serious and life
threatening infections including pneumonia, urinary tract
infections, intravascular line infections, soft tissue infec-
tions, intraabdominal infections and bacteremia. Because
carbapenems are usually the last line of defense for the
treatment of resistant Gram-negative pathogens, the de-
velopment of carbapenemase-producing K. pneumoniae is
of great concern. Carbapenem-resistant K. pneumoniae
(CRKP) has become a major threat and burden to health-
care systems worldwide as most isolates are resistant to
multiple classes and some to all classes of antibiotics mak-
ing treatment difficult if not near impossible. However,
most of these KPC-containing strains especially in the
United States do not contain the virulence factors of the
strains found in Asia resulting in a less invasive clinical
presentation. Likewise, virulent strains of K. pneumoniae
causing invasive disease that are usually found in Asia are
not known to be multi-drug resistant let alone carba-
penem-resistant. However, there have been recent sepa-
rate reports of endemic KPC K. pneumoniae strains and
hypervirulent invasive K. pneumoniae strains found in
New Jersey. This study assesses the possibility of an inva-
sive virulent K2 K. pneumoniae strain and its capability of
acquiring KPC.
Methods
Strains in this study
The two most commonly found KPC strains (KPC-2
and −3) at the Veterans Affairs New Jersey Healthcare
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System (VA NJHCS) were used as donors. A virulent K2
serotype KP isolate from a liver abscess patient in New
Jersey (University Hospital- Rutgers New Jersey Medical
School) was chosen as the recipient [4]. These KPC KP
donor isolates were acquired from the clinical micro-
biology laboratory at the VA NJHCS for this Institutional
Review Board (IRB) approved study (MIRB 00937).
Susceptibility testing
Antimicrobial susceptibility was determined by the broth
microdilution method [5], according to the Clinical and
Laboratory Standards Institute’s (CLSI) guidelines pub-
lished in 2011. The following antimicrobial agents were
used: cefazolin, amoxicillin/clavulanic acid, cefoxitin,
cefotaxime, ceftazidime, imipenem, amikacin, gentami-
cin, ciprofloxacin, and trimethoprim-sulfamethoxazole.
Pulsed-field gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) was performed
as previously described [6]. The resulting genomic DNA
profiles, or fingerprints, were interpreted according to
established guidelines [7,8].
Confirmation of KPC production and KPC types by
sequencing
All isolates selected were confirmed for KPC production
by polymerase chain reaction (PCR). A gene-specific
primer set, KPC-F (5′-ATG TCA CTG TAT CGC CGT
CT-3′) and KPC-R (5′-TTT TCA GAG CCT TAC TGC
CC-3′), was used to determine the presence of the KPC
β-lactamase sequence [9]. The amplicons (893 bp) were
sequenced using an automated sequencer by the Sanger
method (ABI Prism 377 sequencer; Perkin-Elmer) [10].
The generated sequences were compared to the National
Center for Biotechnology Information (NCBI) database
at www.ncbi.nlm.nih.gov/blast/.
Conjugation experiments
The transconjugant of the two most commonly found
KPC strains (KPC-2 and −3) at the VA NJHCS, contai-
ning the KPC plasmid, were used as donors. The viru-
lent K2 serotype Klebsiella pneumoniae (NJ-K2) isolate
from a liver abscess patient in New Jersey was chosen as
the recipient [4]. Inducing streptomycin resistance as a
selection maker in the recipient for conjugation was
performed according to previously described methods by
Tasi et al. [11]. Briefly, the K2 serotype K. pneumoniae
strain was grown in LB broth at 37°C to late-exponential
growth phase and then spread on LB agar plates supple-
mented with 500 μg/ml streptomycin. The cells were in-
cubated at 37°C and spontaneous mutants were obtained
from colonies that arose within 3 days. This isolate pos-
sesses intrinsic resistance only to ampicillin and strepto-
mycin. Mating procedure with KPC-2 and −3 containing
KPC was then performed as previously described [12,13]
except by using specific selection brilliant green agar-
containing inositol-nitrate-deoxycholate (BIND) for K.
pneumoniae [14]. Serotype K2/KPC transconjugants were
selected using the Klebsiella-selective medium BIND sup-
plemented with 2 μg/ml of imipenem and 50 μg/ml of
streptomycin. The virulent K2 serotype KPC K. pneumo-
niae transconjugant was able to grow on the selective
BIND medium with imipenem. Positive transconjugants
were confirmed by positive PCR with specific primer
sequences to serotype K2 [15] and KPC type β-lactamases
genes [16]. Transconjugants from the conjugation expe-
riments were subcultured onto MacConkey or Mueller
Hinton agar (BBL) for 14 days to check for KPC plasmid
stability in KPC strains (KPC-2 and −3) and K. pneumo-
niae after conjugation (Figure 1).
PCR detection of virulence-associated genes rmpA and
aerobactin, and serotypes K1, K2, and K5
PCR experiments to determine the presence of the
specific genes for serotype K1, K2, and K5; rmpA; and
the aerobactin gene were performed as previously
described [15,17].
Multilocus sequence typing (MLST)
MLST were performed according to Turton et al. [18].
Sequences of seven housekeeping genes were obtained for
isolates from liver abscess patients and carriers. Sequence
information was compared with that available from the
MLST website (http://pubmlst.org/kpneumoniae/) deve-
loped by Keith Jolley. Alleles and sequence types (STs)
were assigned accordingly. Sequences of any alleles that
were not in the database were submitted to the curator
and a new allele number obtained. A difference in two or
more alleles was considered to indicate that the sequence
types being compared were unrelated.
Virulence studies
In vitro and in vivo assays to assess virulence were per-
formed by serum resistance, neutrophil phagocytosis and
mice lethality experiments. Neutrophil phagocytosis was
performed as previously described [19]. The recipient
serotype K2 K. pneumoniae (NJ-K2) isolated from a liver
abscess was used as a control strain [4]. This strain is
hypervirulent with a median lethal dose (LD50) < 102
colony forming unit (CFU) and is highly phagocytic
resistance (< 10% of phagocytic rate 15 minutes).
For the determination of LD50 in mice, pathogen-free,
adult, 6-8-week-old, male BALB/c mice weighing 20–25 g
were obtained from the National Laboratory Animal
Center. This study was carried out in strict accordance
with the recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes of
Health. All animal care procedures and protocols were
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approved by the Institutional Animal Care and Use
Committee of the National Health Research Institute
(NHRI-IACUC-096004-A). Tenfold serial dilutions of KP
were made from a starting concentration of 106 CFU, and
the adult BALB/c mice had intraperitoneal injections with
0.1 ml of each concentration. Six mice were used as a
sample population for each bacterial concentration [20].
Signs and symptoms of infection were observed for
14 days.
Survival of the inoculated mice was recorded, and the
LD50 was calculated using SigmaPlot version 7.0 from
SPSS Inc.
Results
Conjugation of plasmids of KPC-2 and −3 into serotype
recipient K2 and antimicrobial susceptibility test of their
transconjugants
In the conjugation experiment, plasmids carrying blaKPC
from KPC-positive K. pneumoniae (KPC-2 and −3) were
successfully transferred into the invasive K2 K. pneu-
moniae recipient isolate (NJ-K2) (Figure 1). Subculture of
serotype K2 K. pneumoniae::blaKPC onto selective agar
plate showed good growth in the selective BIND agar
plate. No plasmid loss after 14 days of subculture onto the
MacConkey or Mueller Hinton agar plate was observed
for K2 K. pneumoniae::blaKPC indicating the stability of
the blaKPC plasmid in K. pneumoniae. All strains were
verified by PCR to ensure that no contamination occurred
during each experiment for donor, recipient of serotype
K2 K. pneumoniae, or transconjugants K2 K. pneumo-
niae::blaKPC.
The KPC-positive K. pneumoniae (KPC-2 and −3) iso-
lates showed 100% resistance to piperacillin-tazobactam,
cefazolin, cefotaxime, ceftazidime, ceftriaxone, ciprofloxa-
cin, cefoxitin, gentamicin, imipenem and/or meropenem.
All β-lactam resistance were maintained in transcon-
jugants while change of susceptibilities from resistance to
susceptible were observed in aminoglycosides and quino-
lones indicating non-plasmid encoding resistance in these
classes of antibiotics (Table 1).
Detection of virulence-associated determinants and mice
lethality experiments
Detection of K1, K2, and K5 virulence-associated sero-
types, and rmpA and aerobactin genes, revealed that
KPC donor isolates were non-Kl, -K2, or -K5 serotypes
and did not carry rmpA and aerobactin virulence genes.
MLST showed that both donor isolates were ST-258 and
recipient serotype K2 was ST-65. Transconjugants carry-
ing plasmid encoding KPC-2 or 3 showed an increasing
resistance to neutrophil phagocytosis in comparing to
donor strains which carry KPC-2 or −3 carbapenemase
(Figure 2). In assessing compliment killing by serum
resistance assay, all the transconjugants were resistant to
serum killing as recipient serotype K2 K. pneumoniae
(Figure 3).
Murine lethality studies by IP injection showed that
LD50 were > 106 CFU for the KPC K. pneumoniae isolates
prior to conjugation, indicating low virulence. In contrast,
LD50 of the transconjugant strain was < 102 CFU after
conjugation while retaining KPC and K2 genes [confirmed
by PCR (Figure 4)]. In order to confirm the stability
Figure 1 Conjugation experiments of plasmids carrying βlaKPC-2 and −3 from parental non-serotype K2 K. pneumoniae to recipient
serotype K2 K. pneumoniae. In this conjugation experiment, plasmids carrying blaKPC from KPC-positive K. pneumoniae (KPC-2 and −3) were
successfully transferred into the invasive K2 K. pneumoniae recipient isolate (NJ-K2). Specifically, DNA extracted from the invasive K2 K. pneumoniae
recipient isolate (NJ-K2) were positive for the blaKPC gene by PCR. Transconjugants, K2 K. pneumoniae::βlaKPC, were obtained by Klebsiella-selective
medium BIND supplemented with 2 μg/ml of imipenem. Colonies were then randomly selected from the plate and subjected for serotype K2 PCR.
Colonies with PCR positive results on serotype determination were sub-cultured onto the same selective agar plate. Sub-culture of K2 K. pneumoniae::
βlaKPC occurred by inoculating onto MacConkey agar plates for 14 consecutive days. Lane 1, PCR verification of recipient serotype K2 isolate from
New Jersey; Lane 2, Control KPC-2 from Taiwan; Lane 3, donor K. pneumoniae with βlaKPC-2, Lane 4, transconjugants K. pneumoniae::βlaKPC-2.
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of KPC-2 or 3 in transconjugants, PCR detection for sero-
type K2 and KPC-2 or 3 were used during the infection
period. PCR of serotype K2 and KPC-2 or 3 were detec-
ted on day 2 and day3 of isolation indicating the KPC-2
or −3 plasmids were stable in the transconjugants during
infection.
Discussion
KPC K. pneumoniae was first reported in the United
States in 2001. Since its first report, KPC K. pneumoniae
has become an increasingly prevalent pathogen and is
now endemic in the Northeastern United States. Its
spread has been well documented worldwide. According
to data from the National Nosocomial Infections Sur-
veillance System Report and the National Healthcare
Safety Network, the proportion of Enterobacteriaceae
that are carbapenem-resistant has increased from 1.2%
in 2001 to 4.2% in 2011. At the VA NJHCS and its affi-
liated University Hospital (Rutgers New Jersey Medical
School), K. pneumoniae is now the second most pre-
valent Gram-negative pathogen with carbapenem re-
sistance rates of 18% and 12% respectively (2012 VA
NJHCS and University Hospital antibiograms). Most of
the CRKP isolates found at these two hospitals are
multi-drug resistant if not pan resistant to all available
antibiotics. Not surprisingly, mortality rates of up to 50%
have been reported in CRKP bacteremia cases due to the
lack of effective antibiotics. Fortunately, CRKP has yet to
be associated with community acquisition.
Invasive KP was initially thought of as a regionally
distributed disease found in the Asia-Pacific Rim. How-
ever, it is now been reported worldwide as an emerging
infectious disease [21]. Its virulence determinants and
phagocytic inhibition has been well studied [22]. Unlike
invasive K. pneumoniae, virulence and plasmid transmis-
sibility of KPC K. pneumoniae have not been well
investigated. Our previous study of virulence in KPC K.
pneumoniae showed that in 60 unique CRKP, none had
the virulent serotypes K1, K2, or K5 nor the virulence
factors of rmpA or aerobactin lending to the assumption
that high rates of morbidity and mortality due to KPC
K. pneumoniae are most likely due to its antibiotic
resistance properties and not its virulence.
This study showed that the combination of an in-
creased virulent strain of K. pneumoniae acquiring KPC
and its associated multidrug associated genes can be
created. Conjugation and retainment of KPC by virulent
K2 K. pneumoniae and the ability of the tranconjugants
to maintain its high serum resistance and lethality after
Table 1 Antimicrobial susceptibility test among donors of
KPC- 2 or −3, recipient and transconjugant
Antibiotics Recipient K2 Donor Transconjugant
KPC-2 KPC-3 KPC-2 KPC-3
Ampicillin ≥32 ≥32 ≥32 ≥32 ≥32
Cefazolin ≤2 ≥32 ≥32 ≥32 ≥32
Cefoxitin ≤4 ≥128 ≥128 ≥128 ≥128
Aztreonam ≤1 ≥32 ≥32 ≥32 ≥32
Cefotaxime ≤1 32 32 8 8
Ceftazidime ≤1 ≥32 ≥32 ≥32 ≥32
Cefepime ≤1 ≥32 16 16 8
Ertapenem ≤0.25 ≥8 ≥8 ≥8 ≥8
Imipenem 0.5 ≥8 ≥8 ≥8 ≥8
Meropenem ≤0.25 ≥8 ≥8 ≥8 ≥8
Doripenem ≤0.12 ≥4 ≥4 ≥4 ≥4
Colistin 1 ≤0.5 ≥4 ≤1 1
Tigecycline ≤0.25 1 ≤0.25 ≤0.25 ≤0.25
Gentamicin ≤1 ≤1 ≥16 ≤1 ≤1
Amikacin ≤4 16 32 ≤4 ≤4
Ciprofloxacin 0.12 ≥4 ≥4 ≤0.06 0.12
Levofloxacin ≤0.5 ≥8 ≥8 ≤0.5 ≤0.5
SXT* ≤0.5 ≥4 ≥4 ≥4 ≤0.5
*Cotrimoxazole.
Figure 2 Neutrophils phagocytosis assays among Isolates of KPC-2 and −3, serotype K2 recipient and their transconjugants.
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conjugation were possible. The ramifications of having a
virulent, multi-drug resistant, KPC-containing K. pneu-
moniae would be disastrous on healthcare systems [23].
Not surprisingly, with continued indiscriminate use of
antibiotics worldwide, KPC-producing K. pneumoniae
has been detected in China with the predominate clone
being ST11 which is unrelated to the current ST258
clone found commonly in KPC K. pneumoniae found in
the United States. With the continued worldwide dis-
semination of KPC, it is likely a matter of time before
the virulent Asian strains of KP will begin to express
KPC carbapenem resistance.
Conclusions
As demonstrated in our study, further dissemination of
the KPC plasmid into virulent types of K. pneumoniae
Figure 3 Serum resistance assays among Isolates of KPC-2 and −3, serotype K2 recipient and their transconjugants.
Figure 4 Mice lethality test among Isolates of KPC-2 and −3, serotype K2 recipient and their transconjugants. The survivals after
inoculation of K. pneumoniae were counted over 14 days. Data points represent the percentage of mice surviving in each experimental group
over time. (n = 6 mice per strain, pooled from two separate experiments).
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cannot be excluded in the future. Efforts to assess the
factors that contribute to attributable mortality in KPC
K. pneumoniae infections should be continued, including
the study of other virulence determinants, antibiotic
resistance, host responses, and their relationship with
clinical characteristics and outcomes.
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